Athira Pharma, Inc.

ATHA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$48,438$90,584$95,966$110,537
Short-Term Investments$2,837$56,835$104,378$143,222
Receivables$0$1,628$1,227$2,336
Inventory$0$0-$1,227$0
Other Curr. Assets$3,566$5,682$7,189$4,704
Total Curr. Assets$54,841$154,729$207,533$260,799
Property Plant & Equip (Net)$3,252$4,437$5,316$5,217
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$631$631$44,829$65,936
Tax Assets$0$0$0$0
Other NC Assets$55$448$475$56
Total NC Assets$3,938$5,516$50,620$71,209
Other Assets$0$0$0$0
Total Assets$58,779$160,245$258,153$332,008
Liabilities
Payables$319$129$2,501$567
Short-Term Debt$414$368$326$288
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$12,402$28,343$18,604$8,437
Total Curr. Liab.$13,135$28,840$21,431$9,292
LT Debt$803$1,217$1,585$1,632
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$803$1,217$1,585$1,632
Other Liabilities$0$0$0$0
Cap. Leases$803$1,585$1,911$1,920
Total Liabilities$13,938$30,057$23,016$10,924
Equity
Pref Stock$0$0$0$0
Common Stock$4$4$4$4
Retained Earnings-$406,146-$309,206-$191,534-$95,895
AOCI$1-$349-$1,956-$388
Other Equity$450,982$439,739$428,623$417,363
Total Equity$44,841$130,188$235,137$321,084
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$58,779$160,245$258,153$332,008
Net Debt-$47,221-$88,999-$94,055-$108,617
Athira Pharma, Inc. (ATHA) Financial Statements & Key Stats | AlphaPilot